The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Redeyemines, really appreciating your posts recently, good to get such good analysis on the cautious side. Your post of 9.32 this morning: that logic would seem to work well with IIs who are already holding, but would a good CPTR not attract the attention of new investors? Or do you reckon most of the action would come from those already holding, looking for the right moment to increase? Thansk in advance
https://www.thetimes.co.uk/article/hopes-soar-in-glencore-on-promise-of-scandal-resolutions-f9569zpcm
Sorry this is behind a paywall. I wonder if anyone who understands this stuff and has access thinks it material to Zanaga?
I would think the lack of any reply would be due to hard and fast rules, rather than any reluctance, whcih is rather the point I was trying to make. Ask yourself, why would he simply not reply at all and attract so much bad feeling? Easier to give an anodyne response and keep the ill will at bay. Also are you assuming that its in Zanaga's interest that more shares be bought now. I wonder if that's the case. Maybe they're trying to keep the share price low - it looks like that to me, every time the price starts to rise there's a 100k, 200k or a couple of 150ks sold, looks like shard doing that tbh. Keeping the mc as low as pos may be a posisitve for ZIOC in any negotiations. What to do the 'big guns' (you know who you are) of LSE reckon? Extrader etc.